Evidence map›Paper›PMID 39081128›Full record

ArticleHuman brain mapping2024

Texture-based morphometry in relation to apolipoprotein ε4 genotype, ageing and sex in a midlife population.

Maria-Eleni Dounavi, Elijah Mak, Gregory Operto, Graciela Muniz-Terrera, Katie Bridgeman, Ivan Koychev, Paresh Malhotra, Lorina Naci, Brian Lawlor, Li Su and 5 more

Abstract read
In one paragraph

Article in Human brain mapping, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Hypothalamic volume, sleep, and APOE genotype in cognitively healthy adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria-Eleni DounaviDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Elijah MakDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Gregory OpertoBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Graciela Muniz-TerreraCentre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Katie BridgemanCentre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Ivan KoychevDepartment of Psychiatry, Oxford University, UK.
Paresh MalhotraDivision of Brain Science, Imperial College Healthcare NHS Trust, UK.
Lorina NaciInstitute of Neuroscience, Trinity College Dublin, University of Dublin, Ireland.
Brian LawlorInstitute of Neuroscience, Trinity College Dublin, University of Dublin, Ireland.
Li SuDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Carles FalconBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Karen RitchieINSERM and University of Montpellier, Montpellier, France.
Craig W RitchieCentre for Dementia Prevention, University of Edinburgh, Edinburgh, UK.
Juan Domingo GispertBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.ORCID 0000-0002-6155-0642
John T O'BrienDepartment of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.

Funding

Alzheimer's Research UK ARUK-SRF2017B-1Fondo de Investigacion Sanitaria (FIS) PI12/00326'La Caixa' FoundationMedical Research Council Dementias Platform UK GrantNIHR Cambridge Biomedical Research Centre BRC-1215-20014NIHR fellowshipsNIHR Imperial Biomedical Research CentreNIHR Oxford Biomedical Research Center'Ramon y Cajal' Fellowship RYC-2013-13054UK Alzheimer's Society 178UK Alzheimer's Society 264US Alzheimer's Association TriBEKa-17-519007
6 · The paper itself

Abstract

Brain atrophy and cortical thinning are typically observed in people with Alzheimer's disease (AD) and, to a lesser extent, in those with mild cognitive impairment. In asymptomatic middle-aged apolipoprotein ε4 (ΑPOE4) carriers, who are at higher risk of future AD, study reports are discordant with limited evidence of brain structural differences between carriers and non-carriers of the ε4 allele. Alternative imaging markers with higher sensitivity at the presymptomatic stage, ideally quantified using typically acquired structural MRI scans, would thus be of great benefit for the detection of early disease, disease monitoring and subject stratification. In the present cross-sectional study, we investigated textural properties of T1-weighted 3T MRI scans in relation to APOE4 genotype, age and sex. We pooled together data from the PREVENT-Dementia and ALFA studies focused on midlife healthy populations with dementia risk factors (analysable cohort: 1585 participants; mean age 56.2 ± 7.4 years). Voxel-based and texture (examined features: contrast, entropy, energy, homogeneity) based morphometry was used to identify areas of volumetric and textural differences between APOE4 carriers and non-carriers. Textural maps were generated and were subsequently harmonised using voxel-wise COMBAT. For all analyses, APOE4, sex, age and years of education were used as model predictors. Interactions between APOE4 and age were further examined. There were no group differences in regional brain volume or texture based on APOE4 carriership or when age × APOE4 interactions were examined. Older people tended to have a less homogeneous textural profile in grey and white matter and a more homogeneous profile in the ventricles. A more heterogeneous textural profile was observed for females in areas such as the ventricles, frontal and parietal lobes and for males in the brainstem, cerebellum, precuneus and cingulate. Overall, we have shown the absence of volumetric and textural differences between APOE4 carriers and non-carriers at midlife and have established associations of textural features with ageing and sex.

Indexed as

AgingApolipoprotein E4Magnetic Resonance ImagingAdultAgedApolipoproteins EBrainCross-Sectional StudiesFemaleGenotypeHeterozygoteHumansMaleMiddle AgedSex CharacteristicsApoE protein, humanApolipoprotein E4Apolipoproteins EageingAlzheimer's diseaseAPOE4dementia riskmorphometryMRItexture

Identifiers

PMID39081128
PMCPMC11289425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.